Brief: Sienna Biopharmaceuticals Says On Sept 18, Bankruptcy Court Entered Interim Order In Connection With Filing Of Chapter 11 Case
23/09/2019 14:28
Sept 23 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS - ON SEPT 18, BANKRUPTCY COURT
ENTERED
INTERIM ORDER IN CONNECTION WITH FILING OF CHAPTER 11 CASE
* SIENNA BIOPHARMACEUTICALS- RECEIVED LETTER FROM NASDAQ
THAT AS A
RESULT OF CHAPTER 11 CASE & IN ACCORDANCE WITH LISTING RULES, CO
WILL BE DELISTED
Source text: (https://bit.ly/2kO7Jpv)
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures